Cetera Investment Advisers’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.07M Buy
30,365
+21
+0.1% +$2.17K ﹤0.01% 2025
2026
Q1
$2.94M Sell
30,344
-216
-0.7% -$22.2K ﹤0.01% 1928
2025
Q4
$3.24M Sell
30,560
-4,802
-14% -$557K ﹤0.01% 1795
2025
Q3
$4.49M Buy
35,362
+11,506
+48% +$1.37M 0.01% 1481
2025
Q2
$2.93M Buy
23,856
+8,022
+51% +$916K ﹤0.01% 1566
2025
Q1
$1.6M Buy
15,834
+1,319
+9% +$129K ﹤0.01% 1911
2024
Q4
$1.34M Buy
14,515
+1,036
+8% +$102K ﹤0.01% 1951
2024
Q3
$1.3M Buy
13,479
+1,126
+9% +$101K ﹤0.01% 1926
2024
Q2
$1.06M Buy
12,353
+664
+6% +$55.7K ﹤0.01% 2032
2024
Q1
$965K Buy
+11,689
New +$856K ﹤0.01% 2095

Other funds holding EHC

Cetera Investment Advisers's EHC Position: Q2 2026 in Review

Cetera Investment Advisers increased its Encompass Health (EHC) stake by 0.07% in Q2 2026, buying an estimated $2.17K and bringing the position to 30,365 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

Cetera Investment Advisers first reported a position in EHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.49M in Q3 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Cetera Investment Advisers held 30,365 shares of Encompass Health worth $3.07M as of Q2 2026.
  • Cetera Investment Advisers bought 21 Encompass Health shares in Q2 2026, an estimated $2.17K.
  • Encompass Health made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2025 holding.
  • Cetera Investment Advisers first reported a position in Encompass Health in Q1 2024 and has held it in 10 quarters since.
  • Cetera Investment Advisers's Encompass Health position peaked at $4.49M in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.